Non–Small Cell Lung Cancer Coverage from Every Angle

Misako Nagasaka, MD, on Sintilimab Plus Chemotherapy for Advanced Nonsquamous Lung Cancer

Posted: Wednesday, September 2, 2020

Misako Nagasaka, MD, of the Barbara Ann Karmanos Cancer Institute, presents interim analysis data from ORIENT-11, and talks about how to give sintilimab safely, and manage and minimize adverse events.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.